U.S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                   Form 10-QSB

[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934
        For the quarterly period ended March 31, 2004

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT
     For the transition period from _________ to __________

Commission file number 33-17387

                          ALLIANCE HEALTH, INC.
   (Exact name of small business issuer as specified in its charter)

        Delaware                                   75-2192377
(State or other jurisdiction of         (IRS Employer Identification
 incorporation or organization)                      No.)


              421 E. Airport Freeway, Irving, Texas 75062
                (Address of principal executive office)

                            (972)-255-5533
                      (Issuer's telephone number)
       ------------------------------------------------------------
          (Former name, former address and former fiscal year,
                      if changed since last year)

Check whether issuer (1) filed all reports required to be filed by Section 13 or
15(d) of the Exchange Act during the past 12 months (or for such shorter period
that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days.
                           Yes   X    No


                  APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date: At March 31, 2004, 1,534,066 shares
of common stock, $0.01 par value, were outstanding.

Transitional Small Business Disclosure Format (Check one):
     Yes      No    X


<page>

                              ALLIANCE HEALTH, INC.

                                      INDEX

                                   PAGE NUMBER

PART I    FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

          Independent Accountants' Report                            1

          Balance Sheets - March 31, 2004 (unaudited) and
            September 30, 2003 (audited)                             2

          Statements of Operations (unaudited) - Three
            Months and Six Months Ended March 31, 2004
            and 2003                                                 3

          Statements of Cash Flows (unaudited) - Six
            Months Ended March 31, 2004 and 2003                     4

          Notes to Financial Statements                             5-6

ITEM 2.   Management's Discussion and Analysis of
            Financial Condition and Results of
            Operations                                               7


ITEM 3.   Controls and Procedures                                    8

PART II   OTHER INFORMATION

ITEM 6.   Exhibits and Reports on Form 8K                            9

SIGNATURES                                                          10




<page>

                         INDEPENDENT ACCOUNTANTS' REPORT





Board of Directors
Alliance Health, Inc.




We have reviewed the accompanying  balance sheet of Alliance Health,  Inc. as of
March 31, 2004, and the related  statements of operations and cash flows for the
three and six month periods then ended.  These interim financial  statements are
the responsibility of the Company's management.

We conducted our review in accordance with standards established by the American
Institute of Certified  Public  Accountants  in the United States of America.  A
review of interim  financial  information  consists  principally  of  analytical
procedures applied to financial data and making inquiries of persons responsible
for financial and accounting  matters. It is substantially less in scope than an
audit in accordance  with auditing  standards  generally  accepted in the United
States of  America,  the  objective  of which is the  expression  of an  opinion
regarding  the financial  statements  taken as a whole.  Accordingly,  we do not
express such an opinion.

Based on our review, we are not aware of any material  modifications that should
be made to the accompanying interim financial statements in order for them to be
in conformity with accounting principles generally accepted in the United States
of America.




                                             /s/Whitley Penn


Dallas, Texas
May 13, 2004



<page>
ITEM 1.  FINANCIAL STATEMENTS

                              ALLIANCE HEALTH, INC.

                                 BALANCE SHEETS

<TABLE>
<CAPTION>
                                                     (Unaudited)      (Audited)
                                                       March 31,    September 30,
                                                         2004           2003
<S>                                                  <C>             <C>
Assets
Current assets:
  Cash and cash equivalents                          $    24,506     $   243,139
  Income taxes receivable                                 14,771               -
  Treasury bills                                            --           500,000
                                                     -----------     -----------

Total assets                                         $    39,277     $   743,139
                                                     ===========     ===========


Liabilities and Stockholders' Equity
Current liabilities:
  Accounts payable                                   $      --       $       307
  Accrued liabilities                                      3,955           7,000
  Income taxes payable                                      --           164,800
                                                     -----------     -----------
Total current liabilities                                  3,955         172,107


Commitments and contingencies                               --              --

Stockholders' equity:
   Common stock, $.01 par, 20,000,000
     shares authorized, 14,360,000
     shares issued, 1,534,066 shares
     outstanding                                         143,600         143,600
   Paid-in capital                                       723,466         723,466
   Retained earnings                                   3,400,814       3,936,524
                                                     -----------     -----------
                                                       4,267,880       4,803,590

   Less 12,825,934 shares of stock
     held in treasury, at cost                         4,232,558       4,232,558
                                                     -----------     -----------

Total stockholders' equity                                35,322         571,032
                                                     -----------     -----------

Total liabilities and stockholders' equity $              39,277     $   743,139
                                                     ===========     ===========
</TABLE>





                 See accompanying notes to financial statements.




                                       -2-

<page>
                              ALLIANCE HEALTH, INC.

                            STATEMENTS OF OPERATIONS

                                   (UNAUDITED)

<TABLE>
<CAPTION>

                                  Three Months Ended         Six Months Ended
                                      March 31,                  March 31,
                                   2004        2003          2004         2003
                                 --------    ---------     ---------   ---------
<S>                            <C>         <C>          <C>          <C>
Continuing Operations
Revenue                        $      --   $       --   $       --   $        --

General and administrative
 expenses                         18,823           --       35,844            --

Other income:
  Interest income                    311           --          311         3,525

Income tax expense
 (benefit)                        (7,153)          --      (13,621)        1,339
                                --------     --------    ---------    ----------

Income (loss) from
 continuing operations           (11,359)          --      (21,912)        2,186

Discontinued operations:
  Income (loss) from
    discontinued operations,
    net of ($38,466),
    ($8,649), ($38,466)
    and $5,440 in income
    taxes, respectively           38,466      (23,338)      38,466        14,678
  Gain on sale, net of
    $0, $0, $0, and $84,439
    in income taxes,
    respectively                      --           --           --       227,740
                                --------     --------    ---------    ----------

Net income (loss)              $  27,107    $ (23,338)  $   16,554   $   244,604
                                ========     ========    =========    ==========

Basic and diluted
 earnings (loss) per
 share:

  Continuing operations        $   (0.01)   $    0.00   $    (0.01)  $      0.00

  Discontinued operations           0.02        (0.01)        0.01          0.05
                                --------    ----------   ----------   ----------

  Net income (loss)            $    0.01    $    (0.01) $    (0.00)  $      0.05
                                ========     =========   =========    ==========

Weighted average number
  of common shares
  outstanding                  1,534,066     2,558,550    1,534,066   4,696,205
                               =========     =========    =========   =========
</TABLE>


                 See accompanying notes to financial statements.

                                       -3-

<page>

                              ALLIANCE HEALTH, INC.

                             STATEMENTS OF CASH FLOWS

                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                      Six Months Ended
                                                         March 31,
                                                    2004           2003
                                                --------------------------
<S>                                            <C>            <C>
Continuing Operations:
Operating Activities:
 Income (loss) from continuing operations:     $   (21,912)   $     2,186
    Adjustments to reconcile income (loss)
    from continuing operations to net cash
    provided by (used in) operating
    activities:
      Deferred income taxes                           --            8,612
      Changes in assets and liabilities:
       Income taxes receivable and payable        (179,571)       192,140
       Accounts payable                               (307)         4,152
       Accrued liabilities                          (3,045)       (58,608)
                                               -----------    -----------

Net cash provided by (used in) operating
 activities                                       (204,835)       148,482

Investing Activities:
  Proceeds from sales and maturities of
    treasury bills                                 500,000      1,500,000
                                               -----------    -----------
  Net cash provided by investing activities        500,000      1,500,000


Financing Activities:
  Purchases of treasury stock                         --       (2,142,558)
  Dividends paid                                  (552,264)          --
                                               -----------    -----------
Net cash used in financing activities             (552,264)    (2,142,558)

Discontinued Operations:
  Operating activities                              38,466      1,994,253
  Investing activities                                --          110,000
  Financing activities                                --       (2,090,000)
                                               -----------    -----------
Net cash provided by discontinued operations        38,466         14,253
                                               -----------    -----------

Net decrease in cash and cash equivalents         (218,633)      (479,823)
Cash and cash equivalents at
  beginning of period                              243,139        715,130
                                               -----------    -----------
Cash and cash equivalents at end of period     $    24,506    $   235,307
                                               ===========    ===========

</TABLE>

                 See accompanying notes to financial statements.


                                       -4-

<page>
                              ALLIANCE HEALTH, INC.

                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)

Note 1.    Basis of Presentation

     The  accompanying  unaudited  financial  statements  have been  prepared in
accordance with accounting principles generally accepted in the United States of
America for interim  financial  information  and with the  instructions  to Form
10-QSB of  Regulation  S-B.  They do not include all  information  and footnotes
required by  accounting  principles  generally  accepted in the United States of
America for complete financial statements.  However, except as disclosed herein,
there has been no material change in the  information  disclosed in the notes to
the financial  statements for the year ended September 30, 2003, included in the
Company's  Annual Report on Form 10-KSB filed with the  Securities  and Exchange
Commission.  The  interim  unaudited  financial  statements  should  be  read in
conjunction with those financial  statements included in the Form 10-KSB. In the
opinion  of  management,   all  adjustments  considered  necessary  for  a  fair
presentation, consisting solely of normal recurring adjustments, have been made.
Operating  results  for the six  month  period  ended  March  31,  2004  are not
necessarily  indicative  of the results that may be expected for the year ending
September 30, 2004.


Note 2.  Organization

     Alliance  Health,  Inc. (the  "Company")  was  incorporated  in Delaware on
September 4, 1987. The Company  previously  offered  advertising  and management
services to medical  clinics at affiliated  companies,  but the Company is now a
public shell as discussed  below under  discontinued  operations.  The Company's
corporate offices are located in Irving, Texas.

Note 3.  Discontinued Operations

     During the year ended  September 30, 1999,  the Company  formed  Chiro-Med,
Inc. ("Chiro-Med"),  a wholly-owned  subsidiary.  Chiro-Med offered chiropractic
services.  Effective  February 29, 2000,  the Company  discontinued  Chiro-Med's
operations.  The Company  sold  Chiro-Med  to one of its  employees  for $27,593
during the year ended  September 30, 2001 through the issuance of a note at 6.3%
interest  maturing  on December 1, 2002.  The gain  connected  with the sale was
deferred and  recognized  as the Company  received  full  collection on the note
receivable during the year ended September 30, 2002.




                                       -5-

<page>
                              ALLIANCE HEALTH, INC.

                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)




Note 3.  Discontinued Operations (continued)

     S.J.  Kechejian,   M.D.,  P.A.  ("Principal   Stockholder")  cancelled  the
agreement with the Company for  advertising  and management  services  effective
August 31,  2002.  The Company had no  specific  business  plans at the time the
agreement  was  cancelled  and the Board of  Directors  elected  to  discontinue
operations  and  sell the  Company's  assets  to its  Principal  Stockholder  in
consideration  for $110,000 in cash and 6,333,333 shares of the Company's common
stock. In December 2002, the Company also purchased 4,955,875  additional shares
of the Company's common stock from the Company's  Principal  Stockholder and the
Principal   Stockholder's  related  trusts  and  foundations  for  an  aggregate
consideration  of  $1,635,439.  In March 2003, the Company  purchased  1,536,726
shares of the  Company's  common stock from  miscellaneous  stockholders  for an
aggregate  consideration of $507,119. All of these respective shares are held in
treasury stock.

Note 4.  Dividend

     A  special  cash  dividend  of  $0.36  per  share,  totaling  $552,264  was
distributed to all stockholders of record on February 5, 2004.

Note 5.  Income Taxes

     In  the  current  quarter,  the  Company  re-evaluated  its  estimated  tax
liabilities  related to its  discontinued  operations and recorded an income tax
benefit of  $38,466,  based on its  finalized  2003 income tax filings and known
income tax exposures.





                                       -6-
<page>



Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
         RESULTS OF OPERATIONS

FORWARD LOOKING STATEMENT AND INFORMATION

     The Company is including  the following  cautionary  statement in this Form
10-QSB to make applicable and take advantage of the safe harbor provision of the
Private  Securities  Litigation  Reform  Act of  1995  for  any  forward-looking
statements  made by, or on behalf of, the  Company.  Forward-looking  statements
include  statements  concerning plans,  objectives,  goals,  strategies,  future
events or performance and underlying assumptions and other statements, which are
other than  statements  of  historical  facts.  Certain  statements in this Form
10-QSB are  forward-looking  statements.  Words such as  "expects,"  "believes,"
"anticipates,"  "may," and "estimates"  and similar  expressions are intended to
identify  forward-looking  statements.  Such statements are subject to risks and
uncertainties  that could cause actual results to differ  materially  from those
projected.  Such risks and  uncertainties  are set forth  below.  The  Company's
expectations,  beliefs  and  projections  are  expressed  in good  faith and are
believed  by  the  Company  to  have  a  reasonable  basis,   including  without
limitation,  management's  examination  of  historical  operating  trends,  data
contained in the Company's  records and other data available from third parties,
but  there  can  be no  assurance  that  management's  expectation,  beliefs  or
projections will result,  be achieved,  or be  accomplished.  The Company has no
obligation to update or revise these  forward-looking  statements to reflect the
occurrence of future events or circumstances.

     The  following  is   management's   discussion   and  analysis  of  certain
significant  factors which have affected the Company's  financial  condition and
results for the periods included in the accompanying financial statements.

Results of Operations and Financial Condition

     The financial  statements for the six months ended March 31, 2003 have been
reclassified to reflect discontinued operations net of applicable taxes.

     S.  J.  Kechejian,  M.D.,  P.A.,  Metroplex  Specialties,  P.A.  and  Metro
Pharmacy,  Inc.  notified  Alliance  Health,  Inc. of their  cancellation of the
ongoing fee arrangements for marketing effective August 31, 2002.




                                       -7-
<page>

     Expenses  for the  three  months  ended  March 31,  2004 and 2003  included
salaries and employee benefits,  and other general and  administrative  costs in
the amount of $18,823  and $0,  respectively.  These same  expenses  for the six
months  ended March 31, 2004 and 2003 were $35,844 and $0,  respectively.  These
expenses were previously  categorized as discontinued  operations prior to April
1, 2003, but as the Company will now continue as a shell company,  these ongoing
expenses will be classified as continuing  operations.  In the current  quarter,
the  Company   re-evaluated  its  estimated  tax  liabilities   related  to  its
discontinued  operations and recorded an income tax benefit of $38,466, based on
its finalized 2003 income tax filings and known income tax exposures.

     On October 28, 2002 the Board of  Directors  determined  it was in the best
interest of the Company to accept an offer from Dr.  Kechejian  to purchase  the
operating property and equipment of the Company in consideration of the transfer
back to the Company of 6,333,333 shares of Alliance common stock and $110,000 in
cash.  The sale of the assets to Dr.  Kechejian was  consummated on November 29,
2002. Simultaneous therewith,  Dr. Kechejian and entities that he controls, sold
back to the Company all of their remaining  shares of common stock, an aggregate
of  4,955,875  shares,  for a total cash  consideration  of  $1,635,439,  or the
audited book value per share as of September 30, 2002 of $0.33.

     On March 15, 2003 the Company concluded its tender offer to purchase shares
for $0.33 per share  from its  stockholders.  The  Company  purchased  1,536,726
shares  for  $507,119.   The  Company  has  1,534,066  shares  of  common  stock
outstanding after completion of the Offer.

     A  special  cash  dividend  of  $0.36  per  share,  totaling  $552,264  was
distributed to all shareholders of record on February 5, 2004.

     The Company is continuing to search for a suitable merger candidate.

Liquidity and Capital Resources

     The Company had cash of $24,506 at March 31, 2004.

Item 3. Controls and Procedures

     (a)  Evaluation of disclosure controls and procedures.

          The  President/Treasurer/Director  of the  Company  has  conducted  an
          evaluation of the effectiveness of the Company's  disclosure  controls
          and procedures  pursuant to Rule 13a-14 under the Securities  Exchange
          Act of 1934 as of the last day of the period  covered  by this  report
          ("Evaluation    Date").    Based    upon    that    evaluation,    the
          President/Treasurer/Director  concluded  that,  as of  the  Evaluation
          Date, the Company's  disclosure controls and procedures were effective
          in  ensuring  that all  material  information  relating to the Company
          required to be filed in this  quarterly  report has been made known to
          him in a timely manner.

     (b)  Changes in internal controls.

          There have been no significant  changes made in the Company's internal
          controls or in other factors that could significantly  affect internal
          controls subsequent to the Evaluation Date.

                                       -8-


<page>
                              ALLIANCE HEALTH, INC.

                           PART II - OTHER INFORMATION



Items 1, 2, 3, 4 and 5 - Not applicable.


Item 6.   Exhibits and Reports on Form 8-K

      (a) Exhibits

          31.1 Certificate  of  Principal  Executive  Officer  required  by Rule
               13a-14(a)  or Rule  15d-14(a) of the  Securities  Exchange Act of
               1934,  as adopted  pursuant to Section 302 of the  Sarbanes-Oxley
               Act of 2002 (filed herewith).
          31.2 Certificate  of  Principal  Financial  Officer  required  by Rule
               13a-14(a)  or Rule  15d-14(a) of the  Securities  Exchange Act of
               1934,  as adopted  pursuant to Section 302 of the  Sarbanes-Oxley
               Act of 2002 (filed herewith).
          32.1 Certificate  of Chief  Executive  Officer  pursuant  to 18 U.S.C.
               Section  1350,  as  adopted   pursuant  to  Section  906  of  the
               Sarbanes-Oxley Act of 2002 (filed herewith).
          32.2 Certificate of Chief  Financial  Officer  pursuant to 18 U. S. C.
               Section  1350,  as  adopted   pursuant  to  Section  906  of  the
               Sarbanes-Oxley Act of 2002 (filed herewith).

      (b) Report on Form 8-K filed February 17, 2004, related to cash dividend.



















                                       -9-

<page>
                                   SIGNATURES


Pursuant  to the  requirements  of the  Section  13 or 15 (d) of the  Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.




DATED:  May 13, 2004                 By:  /s/Sarkis J. Kechejian, M.D.
                                          Sarkis J. Kechejian, M.D.
                                          President, Director and
                                          Treasurer









                                      -10-

<page>
                                                                Exhibit 31.1

                                  CERTIFICATION


I, Sarkis J. Kechejian, M.D., certify that:

1. I have  reviewed  this  quarterly  report on Form 10-QSB of Alliance  Health,
Inc.;

2. Based on my  knowledge,  this  quarterly  report  does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading with respect to the period covered by this report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.  The  registrant's  other  certifying  officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) designed such  disclosure  controls and procedures or caused such  disclosure
controls and  procedures to be designed  under our  supervision,  to ensure that
material  information  relating to the  registrant,  including its  consolidated
subsidiaries, is made known to us by others within those entities,  particularly
during the period in which this quarterly report is being prepared;

b) evaluated  the  effectiveness  of the  registrant's  disclosure  controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures,  as of the end of the period covered
by this report based on such evaluation; and

c) disclosed in this report any change in the registrant's internal control over
financial  reporting that occurred  during the  registrant's  most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected,  or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed,  based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

a) all  significant  deficiencies  and  material  weaknesses  in the  design  or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  registrant's  ability  to  record,  process,
summarize and report financial information; and

b) any  fraud,  whether  or not  material,  that  involves  management  or other
employees who have a significant role in the registrant's  internal control over
financial reporting.

Date:  May 13, 2004


                                                /s/Sarkis J. Kechejian, M.D.
                                                Sarkis J. Kechejian, M.D.
                                                President and Treasurer
                                                Principal Executive Officer

<page>
                                                                Exhibit 31.2

                                  CERTIFICATION

I, Sharilyn J. Bruntz Wilson, certify that:

1. I have  reviewed  this  quarterly  report on Form 10-QSB of Alliance  Health,
Inc.;

2. Based on my  knowledge,  this  quarterly  report  does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading with respect to the period covered by this report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.  The  registrant's  other  certifying  officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) designed such  disclosure  controls and procedures or caused such  disclosure
controls and  procedures to be designed  under our  supervision,  to ensure that
material  information  relating to the  registrant,  including its  consolidated
subsidiaries, is made known to us by others within those entities,  particularly
during the period in which this quarterly report is being prepared;

b) evaluated  the  effectiveness  of the  registrant's  disclosure  controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures,  as of the end of the period covered
by this report based on such evaluation; and

c) disclosed in this report any change in the registrant's internal control over
financial  reporting that occurred  during the  registrant's  most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected,  or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed,  based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

a) all  significant  deficiencies  and  material  weaknesses  in the  design  or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  registrant's  ability  to  record,  process,
summarize and report financial information; and

b) any  fraud,  whether  or not  material,  that  involves  management  or other
employees who have a significant role in the registrant's  internal control over
financial reporting.


Date:  May 13, 2004



                                              /s/Sharilyn J. Bruntz Wilson
                                              Sharilyn J. Bruntz Wilson
                                              Vice President and Secretary
                                              Principal Financial Officer

<page>
                                                                Exhibit 32.1



                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



By signing below, each of the undersigned  officers hereby certifies pursuant to
18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2003,  that,  to his  knowledge,  (i) this  report  fully  complies  with the
requirements  of Section 13(a) or 15(d) of the  Securities  Exchange Act of 1934
and (ii) the  information  contained  in this  report  fairly  presents,  in all
material respects, the financial condition and results of operations of Alliance
Health, Inc.

Signed this ____ day of May, 2004.



/s/Sarkis J. Kechejian, M.D.
Sarkis J. Kechejian, M.D.
President, Director and Treasurer
Chief Executive Officer


<page>
                                                                Exhibit 32.2


                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


By signing below, each of the undersigned  officers hereby certifies pursuant to
18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2003,  that,  to his  knowledge,  (i) this  report  fully  complies  with the
requirements  of Section 13(a) or 15(d) of the  Securities  Exchange Act of 1934
and (ii) the  information  contained  in this  report  fairly  presents,  in all
material respects, the financial condition and results of operations of Alliance
Health, Inc.

Signed this 13 day of May, 2004.



/s/Sharilyn J. Bruntz Wilson
Sharilyn J. Bruntz Wilson
Vice President and Secretary